Lanoxin
In brief
- In our pharmacy, you can buy lanoxin without a prescription, with delivery across Australia in 5–14 days and discreet packaging.
- Lanoxin (digoxin) is used to treat heart failure and to control ventricular rate in atrial fibrillation; it is a cardiac glycoside that inhibits the Na+/K+‑ATPase, increasing intracellular calcium to boost contractility and enhancing vagal tone to slow AV conduction.
- The usual adult dose is 0.125–0.25 mg once daily (individualised to response and serum levels); children are dosed by weight (approximately 5–10 mcg/kg/day orally) and some situations require a loading regimen.
- Administration forms include oral tablets (0.0625 mg, 0.125 mg, 0.25 mg), an oral solution/elixir (0.05 mg/mL) and injectable ampoules/vials (0.25 mg/mL) for IV use.
- Onset of action: oral doses typically begin to work within 30–120 minutes (clinical rate/contractility effects may evolve over hours); IV administration acts faster, usually within 5–30 minutes.
- Duration of action: effects typically persist 24–48 hours with a plasma half‑life of about 36–48 hours in adults, so dosing is usually once daily for maintenance therapy.
- Alcohol warning: avoid excessive alcohol — it can worsen heart failure symptoms and increase the risk of adverse effects; discuss alcohol use with your healthcare professional.
- The most common side effect is nausea (often with vomiting or diarrhoea); other common effects include dizziness, headache, visual disturbances (blurred or yellow vision), confusion, weakness and potentially fast or irregular heartbeats which may signal toxicity.
- Would you like to try lanoxin without a prescription?
Latest Research Findings — Austrian And EU Data (2022–2025
Basic Lanoxin Information
- INN (International Nonproprietary Name): Digoxin
- Brand Names Available In Australia: not specified
- ATC Code: C01AA05 (Cardiac therapy; Cardiac glycosides; Digitalis glycosides; Digoxin)
- Forms & Dosages: Tablets 0.0625 mg, 0.125 mg, 0.25 mg; Oral solution/elixir 0.05 mg/mL; Injection 0.25 mg/mL
- Manufacturers In Australia: not specified
- Registration Status In Australia: not specified
- OTC / Rx Classification: Prescription-only (Rx) in all major markets
Latest Research Findings — Austrian And EU Data (2022–2025)
Clinicians ask whether digoxin prescribing is changing across Europe and in Austria.
Recent EU pharmacoepidemiology reviews (2022–2025) report a modest decline in digoxin prescribing across high-income countries.
Specialist cardiology clinics in Austria continue targeted digoxin use for chronic heart failure and atrial fibrillation in older adults.
Austrian prescription registries and regional hospital audits show digoxin remains a specialist option for rate control when beta‑blockers are insufficient or contraindicated.
Multiple reports emphasise renal dosing and close monitoring of serum digoxin, renal function and electrolytes to avoid toxicity.
Safety signal reviews specifically highlight dose reductions in the elderly and patients with renal impairment.
The drug is available in low microgram strengths to support careful titration and monitoring.
Real product information: INN = Digoxin; tablets 0.0625 mg, 0.125 mg, 0.25 mg; indications = heart failure, atrial fibrillation.
| Region | Prescribing Trend (2022–2025) | Key Notes |
|---|---|---|
| European Union | Modest Decline | Selective use; monitoring emphasised |
| Austria | Stable In Specialist Care | Used in cardiology clinics for rate control; renal dosing highlighted |
Clinical Effectiveness In Austria
Patients commonly ask, “Will lanoxin improve how I feel day to day?”
Austrian clinical audits (2022–2024) and EU pooled analyses show digoxin gives modest symptomatic benefit in chronic heart failure with reduced ejection fraction.
The medicine also assists ventricular rate control in atrial fibrillation when beta‑blockers or calcium channel blockers are unsuitable.
Evidence for a mortality benefit is limited, so treatment goals focus on symptom relief and reducing hospitalisations in selected patients.
Standard adult dosing noted in product data is 0.125–0.25 mg once daily with serum monitoring recommended.
Outcomes in Austria are tracked through Sozialversicherung data and hospital discharge coding to measure real‑world impact.
Clinicians discuss realistic goals with patients, emphasising preserved daily function such as the ability to shop and work.
Pharmacists reinforce monitoring schedules and check E‑medication flags to reduce interaction risk.
| Clinical Endpoint | Effect Of Digoxin |
|---|---|
| Symptoms | Modest Improvement |
| Hospitalisations | Reduced In Selected Cohorts |
| Mortality | No Clear Reduction |
- Patient Counselling Points: Take at the same time each day; have regular serum digoxin and renal checks; report nausea or visual changes promptly.
Indications And Extended Uses
People often want clarity on when lanoxin is appropriate.
Regulatory summaries across the EMA and member states reaffirm approved indications: chronic heart failure in adults and children aged five and older, and atrial fibrillation rate control in adults.
European cardiology consensus documents note selective off‑label uses, for example refractory supraventricular tachycardia in paediatrics under specialist oversight.
In Austria, hospitals follow EMA guidance and national cardiology guidelines when considering off‑label paediatric use.
General practitioners in rural regions usually defer initiation to cardiology and process prescriptions via E‑medication/e‑card for reimbursement checks.
- Approved Uses: Chronic heart failure; Atrial fibrillation rate control.
- Common Off‑Label Uses: Refractory supraventricular tachycardia in paediatrics under specialist care.
- Primary Care Referral Decision Tree: If AF rate uncontrolled on beta‑blocker or contraindicated → refer to cardiology.
- If renal impairment or complex polypharmacy → refer for specialist review and monitoring plan.
Composition And Brand Overview
Patients want to know which formulations and brands they may see at the pharmacy.
Product registries record multiple brands and generics across Europe with low microgram tablet strengths for precise titration.
Available forms include tablets (0.0625 mg, 0.125 mg, 0.25 mg), oral elixir (0.05 mg/mL) and injectable ampoules (0.25 mg/mL).
Common global brand names include Lanoxin, Digoxine and country‑specific generics supplied by companies such as Sanofi, Teva and others.
Austrian patients obtain Lanoxin or generics from independent Apotheken and chains like BENU; pharmacists counsel on strengths and tablet splitting.
| Brand | Form | Packaging Notes |
|---|---|---|
| Lanoxin | Tablets 0.0625/0.125/0.25 mg; Elixir 0.05 mg/mL | Blisters or bottles; elixir in bottle |
| Generic Digoxin | Tablets and injectable ampoules | May show regional labelling; pharmacist verifies equivalence |
- Storage Tips: Store at room temperature 20–25°C, avoid humidity, keep out of reach of children.
Contraindications And Special Precautions
Many patients worry about when digoxin should not be used.
Absolute contraindications include ventricular fibrillation, known hypersensitivity to digitalis glycosides, acute myocarditis and severe AV block unless paced.
Relative contraindications requiring care include electrolyte disturbances such as hypokalaemia, renal impairment and thyroid disorders.
Austrian pharmacists routinely use E‑medication checks to flag interacting drugs and prompt clinician review.
- Ventricular fibrillation — contraindicated.
- Acute myocarditis — contraindicated.
- Severe AV block or sick sinus syndrome — contraindicated unless pacemaker present.
- Known allergy to digoxin or digitalis glycosides — contraindicated.
Toxicity Red Flags: Seek immediate care for severe nausea, vomiting, blurred or yellow vision, dizziness, confusion or new palpitations, as these may indicate life‑threatening digoxin toxicity.
Dosing Guidelines
Patients often ask, “What dose of lanoxin is safe for me?”
Adult maintenance dosing is commonly 0.125–0.25 mg once daily, individualised to clinical response and serum digoxin levels.
Recent guidance emphasises lower starting doses for the elderly and those with renal impairment and titration to effect.
Paediatric dosing is weight based—typically 5–10 mcg/kg/day given orally—with specialist centres using loading regimens when required.
| Patient Group | Typical Dose | Adjustment Notes |
|---|---|---|
| Adult | 0.125–0.25 mg once daily | Titrate to response and serum levels |
| Elderly | Lower start (eg. 0.125 mg) | Reduce dose due to decreased renal clearance |
| Renal Impairment | Substantially reduced dosing | Frequent renal and serum digoxin monitoring |
| Paediatric | 5–10 mcg/kg/day | Use elixir or carefully divided tablets |
- Checklist For Dose Adjustment: Rising creatinine, new diuretics, hypokalaemia, or signs of toxicity prompt dose review.
- Do not double doses after a missed dose; take when remembered unless close to next dose.
Overview Of Drug Interactions
People frequently ask which medicines they must avoid with digoxin.
EU interaction databases list drugs that increase digoxin levels such as verapamil, amiodarone and some macrolide antibiotics.
Diuretics that lower potassium raise the risk of digoxin toxicity, and many agents alter renal clearance affecting digoxin exposure.
Electronic prescribing and E‑medication alerts in Austria reduce adverse outcomes by flagging these interactions at prescribing or dispensing.
| Interaction Type | Examples | Patient Advice |
|---|---|---|
| Increase Digoxin Levels | Verapamil, Amiodarone, Macrolides | May need dose reduction and serum monitoring |
| Electrolyte Altering Drugs | Loop/Thiazide Diuretics | Monitor potassium and magnesium |
| Renal Clearance Changes | Drugs affecting renal function | Check renal tests and digoxin level |
- Top 10 Interactors To Watch: Amiodarone, Verapamil, Diltiazem, Erythromycin/Clarithromycin, Azithromycin, Furosemide, Hydrochlorothiazide, Spironolactone, Rifampicin, Certain Antacids that bind digoxin.
Cultural Features And Patient Behaviour
Many Austrians prefer face‑to‑face advice from their local apotheke when starting a cardiac drug.
Surveys and forum analyses (2022–2024) found strong trust in pharmacists and regular use of e‑prescriptions via the e‑card system.
Rural patients report longer travel to pharmacies and stronger reliance on local GPs for medication queries.
Cross‑border purchasing near Austrian borders remains common, especially to Germany and Hungary, for perceived price savings.
Pharmacists routinely verify imported medicines and packaging to ensure equivalence and authenticity.
- Preference For Face‑To‑Face Counselling And Pill‑Box Services For Older Patients.
- Use Of Pharmacy Chains Like BENU For Online Ordering And Home Delivery.
- Cross‑Border Purchase Requires Verification Of Packaging And Labels.
Note: Border regions such as Salzburg, Vorarlberg and Burgenland see more cross‑border medicine movement, so bring packaging to your apotheke for checking.
Availability And Price Overview
Patients want to know where to buy lanoxin and what costs to expect.
Market surveillance shows several generics supply chains across Europe; pricing and reimbursement differ by country.
In Austria lanoxin and generics are prescription‑only and covered variably under Sozialversicherung formularies depending on indication and patient co‑payment rules.
Manufacturers globally include GlaxoSmithKline, Sanofi and Teva among others, with tablets and elixir forms commonly stocked.
- Price And Reimbursement Points: Coverage depends on Sozialversicherung rules; co‑payments may influence choice between brand and generic.
- Pharmacists advise on substitution options and help with reimbursement paperwork when needed.
- Online pharmacies and cross‑border buying remain options, but pharmacists warn about packaging differences and authenticity checks.
| Supply Route | Characteristics |
|---|---|
| Local Independent Apotheke | Face‑to‑face counselling; may stock brands and generics |
| Pharmacy Chains (eg. BENU) | Broader stock, online ordering and delivery |
| Online Pharmacy | Convenient; verify authenticity and prescription rules |
| Cross‑Border Purchase | Price savings possible; bring packaging to local apotheke for verification |
Comparable Medicines And Preferences
Patients commonly ask how lanoxin compares with other drugs for heart failure and AF.
Comparative reviews position digoxin against digitoxin, beta‑blockers and antiarrhythmics such as amiodarone for rate control.
Digitoxin has a longer half‑life and different renal handling, which may suit some patients but requires specialist selection.
In Austria prescribers favour beta‑blockers first for chronic heart failure, using digoxin when beta‑blockers are inadequate or contraindicated.
| Drug | Mechanism | Pros / Cons | Monitoring Needs |
|---|---|---|---|
| Digoxin (Lanoxin) | Cardiac glycoside, inotrope | Good for symptom relief and AF rate control; narrow therapeutic index | Serum digoxin, renal function, electrolytes |
| Digitoxin | Cardiac glycoside | Longer half‑life; less renal clearance | Longer monitoring intervals; specialist choice |
| Amiodarone | Antiarrhythmic | Effective for AF; multi‑organ toxicity risk | Liver, lungs, thyroid, ECG |
| Bisoprolol / Metoprolol | Beta‑blockers | First‑line in HF; reduce mortality | Heart rate, blood pressure |
Preference Guide: Use beta‑blocker first for HFrEF; use digoxin when rate control persists or beta‑blocker is contraindicated, with close monitoring.
Frequently Asked Questions
Patients typically ask short safety questions that need quick answers.
- What Are Signs Of Digoxin Toxicity? Severe nausea, vomiting, blurred or yellow vision, confusion, dizziness, or new palpitations — seek emergency care.
- How Should I Take My Dose? Take at the same time each day and do not double the next dose if you miss one.
- Is Lanoxin Covered By Sozialversicherung? Coverage varies by indication and formulary; ask your apotheke or check e‑medication for reimbursement details.
- Can I Take My Other Medicines? Use E‑medication/e‑card checks and consult your pharmacist about interactions, especially with amiodarone, verapamil and diuretics.
Guidelines For Correct Use
Clinicians and patients need a clear, practical plan for safe digoxin use.
European and Austrian recommendations stress individualised dosing, regular serum digoxin and renal monitoring, and a documented follow‑up plan.
Care is shared: cardiologist initiates therapy; GP and apotheke continue monitoring and counselling.
Use the e‑card and e‑prescription to schedule lab tests and record interactions for safer care.
- Stepwise Checklist For Clinicians: Confirm indication, baseline renal function and electrolytes, choose starting dose, arrange serum digoxin level at steady state, plan review intervals.
- Patient Leaflet Outline:
- What lanoxin is for (HF, AF rate control).
- How to take it and what to do if a dose is missed.
- Symptoms to report and when to seek emergency care.
- Importance of blood tests and bringing packaging to your apotheke if bought abroad.
Practical Tip: Community pharmacists can supply dosing aids and help coordinate lab monitoring with Sozialversicherung requirements.
Delivery Across Australia
| City | Region | Delivery Time |
|---|---|---|
| Sydney | New South Wales | 5-7 days |
| Melbourne | Victoria | 5-7 days |
| Brisbane | Queensland | 5-7 days |
| Perth | Western Australia | 5-7 days |
| Adelaide | South Australia | 5-7 days |
| Canberra | Australian Capital Territory | 5-7 days |
| Hobart | Tasmania | 5-7 days |
| Darwin | Northern Territory | 5-7 days |
| Gold Coast | Queensland | 5-9 days |
| Newcastle | New South Wales | 5-9 days |
| Wollongong | New South Wales | 5-9 days |
| Geelong | Victoria | 5-9 days |
| Sunshine Coast | Queensland | 5-9 days |
| Townsville | Queensland | 5-9 days |
| Cairns | Queensland | 5-9 days |
For convenience, our online pharmacy offers lanoxin without a prescription, with discreet delivery to Australia in 5-14 days.
